Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ANTIPRO: Warfarin vs Aspirin for Aortic Bioprosthesis
NCT03807921Phase 4Completed
- Sponsor
- Instituto Nacional de Cirugía Cardíaca
- Start
- Jan 2019
- Primary completion
- Dec 2019
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, single-blind trial of warfarin in aortic valve disease (AVD) (2 arms), sponsored by Instituto Nacional de Cirugía Cardíaca. Primary endpoints: Transprosthetic aortic gradient at 1 year and Change in New York Heart Association class at 1 year. Started Jan 2019; status: completed.
02
Drugs
warfarin
03
Conditions
aortic valve disease (AVD)
Beyond the preview
Go deeper on NCT03807921.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03807921.